Le marché des sérums de développement de lignées cellulaires devrait atteindre 1 467,92 millions de dollars américains d'ici 2027, contre 915,58 millions de dollars américains en 2019. Le marché devrait croître avec un TCAC de 6,1 % de 2020 à 2027.
Les médecines régénératives ont le potentiel de remplacer ou de guérir les tissus, ainsi que les organes, et de normaliser les malformations congénitales. Certaines anomalies, maladies et traumatismes liés à l'âge endommagent les tissus et les organes. Au cours de la dernière décennie d'un siècle, l'industrie de l'ingénierie tissulaire a émergé de manière impressionnante et a maintenant évolué vers le domaine plus large de la médecine régénérative, qui se concentre sur le développement de thérapies cliniques pour le maintien, la réparation, le remplacement et l'amélioration de la fonction biologique. , avec l'utilisation de l'ingénierie cellulaire. Le développement de lignées cellulaires est une partie cruciale et invariable de la médecine régénérative. Ainsi, les progrès de la médecine régénérative stimulent la demande de sérum utilisé dans le développement de lignées cellulaires.
Les lignées cellulaires jouent un rôle majeur dans les tests et le développement de médicaments, le développement de la thérapie cellulaire et la recherche liée au cancer tissus, entre autres applications. Les nouveaux médicaments développés dans les sociétés pharmaceutiques sont testés de manière sûre et efficace sur des cellules souches différenciées pour vérifier leur potentiel. De plus, les médecines régénératives utilisant des modèles cellulaires ont le potentiel d'aider les chercheurs dans le traitement d'intervention précoce pour les maladies dégénératives et les blessures traumatiques. Ainsi, l'augmentation de l'utilisation des médicaments régénératifs propulse le marché du sérum de développement de lignées cellulaires.
Marchés régionaux lucratifs pour le sérum de développement de lignées cellulaires
Aperçu du marché
Accroître l'adoption des médecines régénératives
Les médecines régénératives ont le potentiel de remplacer ou de guérir les tissus, ainsi que les organes, et de normaliser les malformations congénitales. Certaines anomalies, maladies et traumatismes liés à l'âge endommagent les tissus et les organes. Au cours de la dernière décennie d'un siècle, l'industrie de l'ingénierie tissulaire a émergé de manière impressionnante et a maintenant évolué vers le domaine plus large de la médecine régénérative, qui se concentre sur le développement de thérapies cliniques pour le maintien, la réparation, le remplacement et l'amélioration de la fonction biologique. , avec l'utilisation de l'ingénierie cellulaire. Le développement de lignées cellulaires est une partie cruciale et invariable de la médecine régénérative. Ainsi, les progrès de la médecine régénérative stimulent la demande de sérum utilisé dans le développement de lignées cellulaires.
Les lignées cellulaires jouent un rôle déterminant dans les tests et le développement de médicaments, le développement de la thérapie cellulaire et la recherche liée aux tissus cancéreux, entre autres applications. Les nouveaux médicaments développés dans les sociétés pharmaceutiques sont testés de manière sûre et efficace sur des cellules souches différenciées pour vérifier leur potentiel. De plus, les médecines régénératives utilisant des modèles cellulaires ont le potentiel d'aider les chercheurs dans le traitement d'intervention précoce pour les maladies dégénératives et les blessures traumatiques. Ainsi, la montée en flèche de l'utilisation de médicaments régénératifs propulse le marché du sérum de développement de lignées cellulaires.
Type Insights
En fonction du type, le développement de la lignée cellulaire Le marché du sérum est segmenté en sérum bovin ftal, sérum bovin adulte, sérum porcin, sérum de cheval et autre sérum animal. En 2019, le segment du sérum bovin ftal représentait la plus grande part du marché. La croissance de ce segment est attribuée à l'augmentation des tests sanguins, des tests d'urine et des différentes procédures d'imagerie.
Marché mondial des sérums pour le développement de lignées cellulaires, par type - 2019 et 2027
Perspectives de l'utilisateur final
Sur la base des applications, le marché mondial des sérums pour le développement de lignées cellulaires est segmenté en ingénierie tissulaire et médicaments régénératifs, tests de toxicité, recherche, découverte de médicaments, bioproduction. En 2019, le segment de la bioproduction détenait la plus grande part de marché ; tandis que le segment de la découverte de médicaments devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision.
Perspectives stratégiques
Les lancements et les approbations de produits sont les stratégies couramment adoptées par les entreprises pour se développer leurs empreintes mondiales et leurs portefeuilles de produits pour répondre à la demande croissante des consommateurs. Les acteurs du marché des sérums de développement de lignées cellulaires adoptent la stratégie de collaborations pour élargir la clientèle dans le monde entier, ce qui leur permet également de conserver leur marque à l'échelle mondiale.
Marché des sérums de développement de lignées cellulaires - par type
- Sérum de veau ftal
- Sérum de veau adulte
- Sérum de porc
- Sérum de cheval
- Sérum d'autres animaux
- Bioproduction
- Découverte de médicaments
- Ingénierie tissulaire et médicaments régénératifs
- Recherche universitaire
- Amérique du Nord
- États-Unis
- Canada
- Mexique
- Europe
- France
- Allemagne
- Italie
- Royaume-Uni
- Espagne
- Reste de l'Europe
- Asie-Pacifique ( APAC)
- Chine
- Inde
- Corée du Sud
- Japon
- Australie
- Reste de l'Asie-Pacifique
- Moyen-Orient & ; Afrique (MEA)
- Afrique du Sud
- Arabie saoudite
- EAU
- Reste du Moyen-Orient & ; Afrique
- Amérique du Sud et centrale
- Brésil
- Argentine
- Reste de l'Amérique du Sud
- Lonza
- Thermo Fisher Scientific Inc.
- Sigma-Aldrich Corporation (Merck KGaA)
- (Cytiva) Danaher
- PAN Biotech
- Corning Incorporated
- Collection européenne de cultures cellulaires (ECACC)< /li>
- Bovogen Biologicals Pty Ltd.
- WuXi AppTec
- Groupe ATCC (American Type Culture Collection)
Marché des sérums pour le développement de lignées cellulaires Par application
< li>Tests de toxicité
Marché des sérums de développement de lignées cellulaires - par géographie
Profils des entreprises
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The cell line is established cell culture, wherein the cells multiply in the apt growth medium and space for growth. Different cell lines are made from other cells. The cell line development market growth is mainly attributed to the serum is broadly important as a source of growth and adhesion factors, lipids, hormones, and minerals for cells' culture in basal media. Besides, the serum also regulates cell membrane permeability and serves as a carrier for lipids, enzymes, micronutrients, and trace elements into the cell.
Increasing Adoption of Regenerative Medicines s expected to propel the growth of the Cell Line Development Serum market. Moreover, rising R&D investments and collaborations among by pharmaceutical and biotechnology companies.
The price of Cell Line Development Serum treatment is $ 168.80 for for fetal bovine serum and HyClone Cosmic Calf Serum, New Zealand origin cost at $ 256.00 USD. However, the cost profoundly differs based upon the customization
The List of Companies - Cell Line Development Serum Market
- Lonza
- Thermo Fisher Scientific Inc.,
- Sigma-Aldrich Corporation (MERCK KGaA)
- Cytiva (Danaher)
- PAN Biotech
- Corning Incorporated
- European Collection of Cell Cultures (ECACC)
- Bovogen Biologicals Pty Ltd.
- WuXi AppTec
- American Type Culture Collection (ATCC)
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Nov 2020
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Nov 2020
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2020
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Nov 2020
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Nov 2020
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Nov 2020
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Nov 2020
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)